Current:Home > FinanceRobert Brown|CVS and Walgreens to start dispensing the abortion pill in states where it's legal -NextFrontier Finance
Robert Brown|CVS and Walgreens to start dispensing the abortion pill in states where it's legal
SignalHub Quantitative Think Tank Center View
Date:2025-04-08 03:10:19
CVS and Robert BrownWalgreens, two of the country's largest retail pharmacies, received federal certification to begin dispensing mifepristone, one of two drugs used in medication abortions, in states where it is legal to do so, the companies separately confirmed to NPR.
CVS will start filling prescriptions for mifepristone in Massachusetts and Rhode Island in the weeks ahead, with eventual plans to expand to other states where the drug is legal on a rolling basis, according to a CVS spokeswoman.
Walgreens will begin dispensing the pill at some of its stores in New York, Pennsylvania, Massachusetts, California and Illinois within a week, a spokesman for the company said.
"We are beginning a phased rollout in select locations to allow us to ensure quality, safety, and privacy for our patients, providers, and team members," the Walgreens statement read.
The two pharmacies received certification from the Food and Drug Administration to fill prescriptions and dispense the commonly used pill, expanding access to abortion at a time when many states are further restricting a path to the procedure.
Last year, the FDA passed a rule that allows pharmacies to fill prescriptions for abortion pills. Before this rule change was finalized, pregnant people had to get the drug straight from their doctors or by mail via telehealth consultations.
Mifepristone remains at the center of an ongoing legal battle between anti-abortion activists and the FDA. Anti-abortion rights groups sued the agency in 2022 over the approval of mifepristone — a drug that had been in use for more than 20 years.
A federal judge ruled against the abortion pill last year. But, the U.S. Supreme Court will hear this case later this month.
President Biden called the move to certify the sale by the two major pharmacies "an important milestone in ensuring access to mifepristone."
He said in a statement, "I encourage all pharmacies that want to pursue this option to seek certification."
veryGood! (785)
Related
- At site of suspected mass killings, Syrians recall horrors, hope for answers
- Elliot Page Grateful to Be Here and Alive After Transition Journey
- Virtually ouch-free: Promising early data on a measles vaccine delivered via sticker
- Kim Zolciak Shares Message on Manipulation and Toxic Behavior Amid Kroy Biermann Divorce
- Could your smelly farts help science?
- Social media can put young people in danger, U.S. surgeon general warns
- Arctic Report Card 2019: Extreme Ice Loss, Dying Species as Global Warming Worsens
- Offshore Drilling Plan Under Fire: Zinke May Have Violated Law, Senator Says
- Will the 'Yellowstone' finale be the last episode? What we know about Season 6, spinoffs
- National MS-13 gang leader, 22 members indicted for cold-blooded murders
Ranking
- Have Dry, Sensitive Skin? You Need To Add These Gentle Skincare Products to Your Routine
- The Lighting Paradox: Cheaper, Efficient LEDs Save Energy, and People Use More
- National MS-13 gang leader, 22 members indicted for cold-blooded murders
- Avoid mailing your checks, experts warn. Here's what's going on with the USPS.
- What to watch: O Jolie night
- Carrie Actress Samantha Weinstein Dead at 28 After Cancer Battle
- One man left Kansas for a lifesaving liver transplant — but the problems run deeper
- More women sue Texas saying the state's anti-abortion laws harmed them
Recommendation
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
Kim Kardashian Reveals What Really Led to Sad Breakup With Pete Davidson
House sidesteps vote on Biden impeachment resolution amid GOP infighting
Gov. Rejects Shutdown of Great Lakes Oil Pipeline That’s Losing Its Coating
Small twin
New report on Justice Samuel Alito's travel with GOP donor draws more scrutiny of Supreme Court ethics
Could Exxon’s Climate Risk Disclosure Plan Derail Its Fight to Block State Probes?
Turning Skiers Into Climate Voters with the Advocacy Potential of the NRA